通过使用VIPCare - - 为痴呆症护理人员提供虚拟互动程序 - - 通过人工智能保护自我
Linda Francis1, Moojan Ghafurian2
1Department of Criminology and Sociology, Cleveland State University, Cleveland, OH, United States.
Frontiers in sociology
|February 20, 2024
概括
本研究介绍了VIPCare,这是一种使用影响控制理论的AI工具,用于改善阿尔茨海默病和相关痴呆症 (ADRD) 患者的互动. 该技术通过模拟患者的情绪来支持护理人员,减少痛苦并提高幸福感.
科学领域:
- 社会学 社会学 社会学
- 人工智能的人工智能
- 老年学是指老年学的学科.
背景情况:
- 辅助技术主要针对身体需求,忽视了残疾人的认知和心理支持.
- 理论社会科学提供了对"看不见"问题的见解,对于理解认知和心理挑战至关重要.
- 阿尔茨海默氏症和相关痴呆症 (ADRD) 具有显著的相互作用,对患者和护理人员都有挑战.
研究的目的:
- 通过开发用于认知和心理支持的AI应用程序来弥合辅助技术的差距.
- 应用影响控制理论 (ACT) 来建模和改善ADRD患者的社交互动.
- 创建一个护理人员支持工具 (VIPCare),增强ADRD患者的互动和情感福祉.
主要方法:
- 使用的影响控制理论 (ACT) 维度:评估,效力和活动.
- 通过工作人员重点小组和采访ADRD患者家属收集的数据.
- 根据日常需求和个人历史制定了居民自我感受配置文件,以编程VIPCare应用程序.
主要成果:
- 开发了一个基于手机的辅助工具VIPCare,结合了基于ACT的社会学理论.
- 产生的情感智能社会互动量身定制为个别居民的自我感受概况.
- 证明了该应用程序减少偏离既定情绪的能力,从而减轻负面情绪.
结论:
- VIPCare模拟基于自我感受而不是认知记忆的社交互动,为ADRD护理提供了一种新的方法.
- 该工具减少了护理人员和患者参与的试错,平滑互动.
- VIPCare有潜力显著改善痴呆症患者的福祉,这是一个易受痛苦影响的人群.
相关概念视频
01:30Cognitive Development During Adulthood
109
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
109
01:16Non-equilibrium in the Cell
4.4K
An important concept in studying metabolism and energy is that of chemical equilibrium. Most chemical reactions are reversible. They can proceed in both directions, releasing energy into their environment in one direction, and absorbing it from the environment in the other direction. The same is true for the chemical reactions involved in cell metabolism, such as the breaking down and building up of proteins into and from individual amino acids, respectively. Reactants within a closed system...
4.4K
01:20Introduction to Cognitive Psychology
481
Cognitive psychology is the field of psychology dedicated to examining how people think. It attempts to explain how and why we think the way we do by studying the interactions among human thinking, emotion, creativity, language, and problem-solving, as well as other cognitive processes. Cognitive psychology studies how information is processed and manipulated in remembering, thinking, and knowing.
This field emerged in the mid-20th century, following a period dominated by behaviorism, which...
This field emerged in the mid-20th century, following a period dominated by behaviorism, which...
481
01:30Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
02:16Self-Schemas
31.1K
In general, a schema is a mental construct consisting of a cluster or collection of related concepts (Bartlett, 1932). There are many different types of schemata, and they all have one thing in common: schemata are a method of organizing information that allows the brain to work more efficiently. When a schema is activated, the brain makes immediate assumptions about the person or object being observed.
31.1K
01:22Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189